Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.42 Insider Own2.73% Shs Outstand30.87M Perf Week14.16%
Market Cap39.45M Forward P/E- EPS next Y-1.00 Insider Trans0.00% Shs Float29.75M Perf Month20.48%
Income-42.56M PEG- EPS next Q-0.20 Inst Own15.70% Short Float / Ratio2.24% / 8.87 Perf Quarter7.50%
Sales4.66M P/S8.47 EPS this Y-2350.00% Inst Trans-16.12% Short Interest0.67M Perf Half Y18.35%
Book/sh3.25 P/B0.40 EPS next Y-11.11% ROA-33.18% Target Price3.00 Perf Year-57.14%
Cash/sh2.07 P/C0.62 EPS next 5Y- ROE-36.31% 52W Range0.98 - 3.33 Perf YTD-48.81%
Dividend- P/FCF- EPS past 5Y6.41% ROI-41.83% 52W High-61.26% Beta-0.49
Dividend %- Quick Ratio13.10 Sales past 5Y7081.14% Gross Margin36.69% 52W Low32.31% ATR0.14
Employees145 Current Ratio13.99 Sales Q/Q-51.77% Oper. Margin-893.32% RSI (14)55.41 Volatility11.05% 13.11%
OptionableYes Debt/Eq0.03 EPS Q/Q-369.35% Profit Margin-913.67% Rel Volume1.07 Prev Close1.18
ShortableYes LT Debt/Eq0.02 EarningsNov 09 AMC Payout- Avg Volume75.16K Price1.29
Recom3.00 SMA203.30% SMA5013.35% SMA200-10.37% Volume80,763 Change9.32%
Date Action Analyst Rating Change Price Target Change
Aug-12-22Downgrade Sidoti Buy → Neutral $5
Dec-29-21Initiated Sidoti Buy $14
Mar-29-21Downgrade Maxim Group Buy → Hold
May-20-20Upgrade Maxim Group Hold → Buy
May-18-20Reiterated H.C. Wainwright Buy $20 → $35
Mar-09-20Reiterated H.C. Wainwright Buy $4 → $20
Mar-03-20Downgrade Maxim Group Buy → Hold
Nov-29-23 09:30AM
Nov-10-23 03:11PM
Nov-09-23 04:01PM
Nov-02-23 09:30AM
09:30AM Loading…
Oct-31-23 09:30AM
Oct-26-23 09:30AM
Oct-23-23 09:30AM
Oct-16-23 09:30AM
Sep-27-23 09:30AM
Sep-22-23 09:30AM
Sep-21-23 09:30AM
Sep-07-23 09:30AM
Aug-29-23 09:30AM
Aug-18-23 09:30AM
11:30AM Loading…
Aug-16-23 11:30AM
Aug-13-23 07:51AM
Aug-11-23 05:21AM
Aug-10-23 05:15PM
Jul-27-23 09:30AM
Jul-20-23 09:30AM
Jul-18-23 09:30AM
Jul-13-23 09:30AM
May-18-23 07:21AM
May-11-23 05:25PM
May-09-23 09:30AM
May-05-23 10:35AM
Apr-26-23 09:30AM
09:30AM Loading…
Apr-13-23 09:30AM
Mar-23-23 09:26AM
Mar-21-23 09:39AM
Mar-20-23 10:46PM
Mar-17-23 09:30AM
Mar-16-23 05:45PM
Mar-09-23 09:30AM
Mar-02-23 09:30AM
Feb-28-23 12:11PM
Feb-22-23 09:30AM
Feb-02-23 09:30AM
Jan-24-23 09:30AM
Jan-05-23 09:30AM
Dec-03-22 07:25AM
Nov-30-22 10:00AM
Nov-16-22 05:17AM
Nov-14-22 09:30AM
Nov-12-22 07:34AM
Nov-10-22 04:13PM
Nov-03-22 02:41PM
Nov-01-22 09:30AM
Oct-27-22 09:30AM
Oct-26-22 09:30AM
Oct-19-22 09:30AM
Oct-14-22 08:41AM
Sep-27-22 06:00AM
Sep-14-22 09:30AM
Sep-12-22 09:30AM
Aug-31-22 09:30AM
Aug-22-22 11:30AM
Aug-15-22 06:03PM
Aug-12-22 07:17AM
Aug-11-22 04:01PM
Aug-09-22 05:09PM
Aug-07-22 09:19AM
Jul-27-22 09:30AM
Jul-26-22 09:30AM
Jul-20-22 09:30AM
Jul-11-22 11:44AM
Jul-05-22 11:19AM
Jun-28-22 09:30AM
Jun-24-22 06:00AM
Jun-15-22 09:30AM
Jun-14-22 02:45PM
Jun-09-22 09:30AM
May-26-22 06:01PM
May-19-22 09:30AM
May-12-22 04:01PM
May-07-22 08:14AM
May-03-22 09:30AM
Apr-28-22 09:30AM
Apr-22-22 09:30AM
Apr-19-22 09:30AM
Apr-14-22 10:01AM
Mar-25-22 07:03PM
Mar-24-22 04:01PM
Mar-22-22 09:30AM
Mar-17-22 09:30AM
Mar-16-22 02:30AM
Mar-15-22 01:15PM
Mar-14-22 09:30AM
Feb-28-22 01:02PM
Feb-17-22 09:30AM
Feb-10-22 09:30AM
Feb-03-22 09:30AM
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brown Brian LeeChief Financial OfficerMar 20Buy1.903,0005,69776,236Mar 21 05:13 PM